POPULARITY
13 episodes with Polypharmacy
7 episodes with Polypharmacy
4 episodes with Polypharmacy
2 episodes with Polypharmacy
3 episodes with Polypharmacy
3 episodes with Polypharmacy
2 episodes with Polypharmacy
2 episodes with Polypharmacy
2 episodes with Polypharmacy
On this episode of Vitality Radio, Jared explores a heartbreaking and highly publicized case involving postpartum mental health struggles, multiple psychiatric prescriptions, and the devastating consequences that followed. Using publicly documented court records and prescription timelines, he examines the challenges of polypharmacy, fragmented care, and the importance of patients actively participating in their own health decisions. Jared also discusses research surrounding mental health, the gut-brain connection, nutrient status, methylation, and other foundational factors that may influence emotional well-being. Drawing from his wife Jen's personal journey, he shares a message of hope and resilience for those facing anxiety, depression, or other mental health challenges. This episode encourages listeners to ask questions, seek understanding, and explore a more comprehensive approach to supporting both body and mind.Additional Information:#264: Emotional Vitality: Jen's Story Part 1 - From Addiction and Mental Illness to Vitality#423: Emotional Vitality: Jen's Story Part 2 - Rebalancing Mind and Body Through Supplementation#438: Emotional Vitality: Jen's Story Part 3 - Weaning Off of Pharma#457: Emotional Vitality: Jen's Story Part 4 - How Changing Your Mindset Can Change Your Life #505: Emotional Vitality: Jen's Story Part 5 - The Impact of Diet on Mental Health and Physical Pain#601: Folate vs. Folic Acid and the Importance of B12 and B6 as the Methylation TeamVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.This podcast is produced by DrTalks.comhttps://drtalks.com/podcast-service/
Roughly 1 in 4 American adults are taking 5 or more prescription medications at the same time, and that number climbs steeply for people over 40, for postpartum women, and for anyone managing more than one chronic condition. The most talked about murder trial of the year has put a public face on what polypharmacy looks like at its most extreme. I break down the polypharmacy conversation, walking through why national health systems in the UK, Scotland, Ireland, and the US have all written formal frameworks for managing the medication burden, why that alone tells you this is the standard rather than the exception.Topics discussed: - The 1 in 4 American Polypharmacy Statistic- National Frameworks for Managing Medication Burden- The Prescription Cascade in Younger Women- The Endocrine and Psychiatric Overlap- Postpartum Thyroid Conditions and Depression- The Thyroid-to-Prolactin Cascade- Nutrient Deficiencies That Look Like Depression- The Lab Panel to Run Before Prescribing---------- My Live Program for Coaches: The Functional Nutrition and Metabolism Specialization www.metabolismschool.com---------- [Free] Metabolism School 101: The Video Serieshttp://www.metabolismschool.com/metabolism-101----------Subscribe to My Youtube Channel: https://youtube.com/@sammillerscience?si=s1jcR6Im4GDHbw_1----------Grab a Copy of My New Book - Metabolism Made Simple---------- Stay Connected: Instagram: @sammillerscienceYoutube: SamMillerScience Facebook: The Nutrition Coaching Collaborative CommunityTikTok: @sammillerscience----------“This Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast and the show notes or the reliance on the information provided is to be done at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment and is for educational purposes only. Always consult your physician before beginning any exercise program and users should not disregard, or delay in obtaining, medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. By accessing this Podcast, the listener acknowledges that the entire contents and design of this Podcast, are the property of Oracle Athletic Science LLC, or used by Oracle Athletic Science LLC with permission, and are protected under U.S. and international copyright and trademark laws. Except as otherwise provided herein, users of this Podcast may save and use information contained in the Podcast only for personal or other non-commercial, educational purposes. No other use, including, without limitation, reproduction, retransmission or editing, of this Podcast may be made without the prior written permission of Oracle Athletic Science LLC, which may be requested by contacting the Oracle Athletic Science LLC by email at operations@sammillerscience.com. By accessing this Podcast, the listener acknowledges that Oracle Athletic Science LLC makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in this Podcast."
Roughly a quarter of American adults are taking five or more prescription medications at the same time, and that number climbs steeply past age 40. It shows up in national survey data, in Medicare data, and in European population studies, so it's a feature of the Western medical world, not a quirk of one system. Health systems have written entire national guidance documents whose only job is managing the resulting polypharmacy, which is the clearest sign that this is the standard rather than the exception. The most talked about murder trial of the year has put a public face on what polypharmacy looks like at its most extreme, but the everyday version of this story is playing out in millions of primary care offices, OB follow-ups, and more. Inside today's episode, I break down the polypharmacy conversation, walking through why national health system have all written formal frameworks for managing the medication burden, why that alone tells you this is the standard rather than the exception, and how the cascade of prescriptions tends to unfold.---------- My Live Program for Coaches: The Functional Nutrition and Metabolism Specialization www.metabolismschool.com---------- [Free] Metabolism School 101: The Video Serieshttp://www.metabolismschool.com/metabolism-101----------Subscribe to My Youtube Channel: https://youtube.com/@sammillerscience?si=s1jcR6Im4GDHbw_1----------Grab a Copy of My New Book - Metabolism Made Simple---------- Stay Connected: Instagram: @sammillerscienceYoutube: SamMillerScience Facebook: The Nutrition Coaching Collaborative CommunityTikTok: @sammillerscience----------“This Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast and the show notes or the reliance on the information provided is to be done at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment and is for educational purposes only. Always consult your physician before beginning any exercise program and users should not disregard, or delay in obtaining, medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. By accessing this Podcast, the listener acknowledges that the entire contents and design of this Podcast, are the property of Oracle Athletic Science LLC, or used by Oracle Athletic Science LLC with permission, and are protected under U.S. and international copyright and trademark laws. Except as otherwise provided herein, users of this Podcast may save and use information contained in the Podcast only for personal or other non-commercial, educational purposes. No other use, including, without limitation, reproduction, retransmission or editing, of this Podcast may be made without the prior written permission of Oracle Athletic Science LLC, which may be requested by contacting the Oracle Athletic Science LLC by email at operations@sammillerscience.com. By accessing this Podcast, the listener acknowledges that Oracle Athletic Science LLC makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in this Podcast."
Thirteen psychiatric drugs. Seven prescribers. Four months. Three dead children. Everyone knows what Lindsay Clancy did. Almost nobody knows what was done to her first. Her husband told them the drugs were making her worse. A hospital team wrote it in her chart. She said it herself, over and over, in her own words, in writing. There is a note in that record explaining why nobody listened. One phrase. It is the reason this keeps happening, and once you hear it you will not be able to unhear it. Dr. Roger McFillin lays out the timeline and the question nobody is asking in that court room.
Dr. Ted Lain welcomes Dr. Mona Shariari — Associate Clinical Professor of Dermatology at Yale School of Medicine, Associate Director of Clinical Trials at Central Connecticut Dermatology, and host of the Medical Sisterhood Podcast — for a deep dive into one of dermatology's most persistent challenges: polypharmacy and topical confusion.Ted and Mona look back at the old-school regimens dermatologists used to write out — one topical for the face, another for the body, different products for weekdays versus weekends — and how that complexity set patients up for poor adherence and side effects like skin thinning and hypopigmentation from steroid overuse. They discuss why once-daily, non-steroidal options like roflumilast cream and foam have changed the equation, allowing head-to-toe use without the body surface area and duration limits that come with topical steroids.Got a question or an idea for a future episode? Email questions@scienceofskinsummit.comJoin us at the Science of Skin Summit in Austin, TX this September, and the Science of Skin Longevity Summit in Scottsdale, AZ in February 2027. Details at scienceofskinsummit.comIf you enjoyed this episode, please subscribe and leave a 5-star rating — word of mouth is how this podcast grows!Follow and Listen to the Podcast Here:
Dr. Ted Lain welcomes Dr. Mona Shariari — Associate Clinical Professor of Dermatology at Yale School of Medicine, Associate Director of Clinical Trials at Central Connecticut Dermatology, and host of the Medical Sisterhood Podcast — for a deep dive into one of dermatology's most persistent challenges: polypharmacy and topical confusion.Ted and Mona look back at the old-school regimens dermatologists used to write out — one topical for the face, another for the body, different products for weekdays versus weekends — and how that complexity set patients up for poor adherence and side effects like skin thinning and hypopigmentation from steroid overuse. They discuss why once-daily, non-steroidal options like roflumilast (Zoryve) cream and foam have changed the equation, allowing head-to-toe use without the body surface area and duration limits that come with topical steroids.Topics covered include:Why systemic absorption is a bigger concern with topical steroids in pediatric patientsClinical trial insights on roflumilast for seborrheic dermatitis, atopic dermatitis, and psoriasisThe foam formulation's use in sensitive areas like the scalp, face, and skin foldsHow roflumilast compares to older PDE4 inhibitors and topical calcineurin inhibitorsWhy the drug's mechanism works across both TH1- and TH2-driven inflammationThe impact of once-daily dosing on patient compliance and long-term outcomesPractical tips for talking to patients transitioning off topical steroidsThis episode is sponsored by Arcutis Biotherapeutics, makers of Zoryve (roflumilast).Got a question or an idea for a future episode? Email questions@scienceofskinsummit.comJoin us at the Science of Skin Summit in Austin, TX this September, and the Science of Skin Longevity Summit in Scottsdale, AZ in February 2027. Details at scienceofskinsummit.comIf you enjoyed this episode, please subscribe and leave a 5-star rating — word of mouth is how this podcast grows!
TODAY ON THE ROBERT SCOTT BELL SHOW: Polypharmacy Death Risk, Dr. Shonna Calica, Annalisa Percy RN, Global Natural Health Solutions, Hormonal Homeopathic Care, Cyclospora Skinny Trend, Medical Reform Failure, Jennifer Margulis, Anna Bazarnaya, Writing Under The Tuscan Sun, Lepidium Bonariense, and MORE! https://robertscottbell.com/polypharmacy-death-risk-dr-shonna-calica-annalisa-percy-rn-hormonal-homeopathic-care-cyclospora-skinny-trend-medical-reform-failure-jennifer-margulis-anna-bazarnaya-lepidium-bonariense-and-m/ Purpose and Character The use of copyrighted material on the website is for non-commercial, educational purposes, and is intended to provide benefit to the public through information, critique, teaching, scholarship, or research. Nature of Copyrighted Material Weensure that the copyrighted material used is for supplementary and illustrative purposes and that it contributes significantly to the user's understanding of the content in a non-detrimental way to the commercial value of the original content. Amount and Substantiality Our website uses only the necessary amount of copyrighted material to achieve the intended purpose and does not substitute for the original market of the copyrighted works. Effect on Market Value The use of copyrighted material on our website does not in any way diminish or affect the market value of the original work. We believe that our use constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the U.S. Copyright Law. If you believe that any content on the website violates your copyright, please contact us providing the necessary information, and we will take appropriate action to address your concern.
A scale. A phone call at the end of the week. A data alert at 6 a.m. Monday morning. These aren't high-tech fantasies — they're the tools that are quietly keeping people out of hospitals and in their homes. In Part 2 of this two-part conversation, Jamie and Brody Wall, Division President of Operations at Your Health, go inside what data-driven care actually looks like on the ground — for the staff delivering it and the patients whose lives depend on it. This episode is less about the architecture of the system and more about what happens when you turn it on. Jamie and Brody cover: The Monday and Tuesday ER spike — and what the data revealed about a weekend coverage gap that was hiding in plain sight How remote patient monitoring caught a CHF patient's five-pound weight gain before it became a Monday emergency room visit — and what that prevented What staff data reveals about burnout, scheduling, and where care quietly falls through the cracks The math that should change how every healthcare organization operates: $800,000 in proactive primary care versus $16 million in hospitalizations for the same 800 patients A hip fracture story — and the 80% mortality statistic behind it — that captures everything Your Health is trying to prevent before it ever becomes a catastrophe This episode is about what it looks like when an organization decides that data isn't there to watch over people — it's there to protect them. If you have a parent, a patient, or a neighbor who deserves this kind of care, share this episode with them. www.YourHealth.Org
Tony brings more than thirty years of experience to a thoughtful conversation about what makes homeopathy both enduring and effective. Drawing from his own journey into the profession, he reflects on the mentors, historical moments, and educational developments that shaped homeopathy in the UK while making the case for keeping its core principles simple and accessible. We also explore different prescribing approaches, the role of awareness in healing, and why understanding the character of each remedy matters more than getting lost in complicated theories. Tony closes by sharing the materia medica resources he values most and encouraging practitioners to build a strong foundation in the essentials of homeopathy. Episode Highlights: 02:13 - Tony's Early Influences and Experiences 10:02 - The State of Homeopathy in the 70s 14:16 - The Influence of George Vithoulkas 19:37 - Tony's approach in teaching materia medica 23:06 - The Spectrum of Remedies 25:55 - Case Taking and the Role of Insight 28:16 - The Challenge of Complexity in Homeopathy 32:09 - Polypharmacy vs. Classical Homeopathy 35:55 - The Importance of Transparency in Prescribing 39:49 Best Materia Medica Books 44:17 Heart Sing Advice About my Guests: Tony is one of the most experienced lecturers in the UK. He witnessed the resurgence of homeopathy in the late '60s and '70s and studied with Thomas Maughan, a leading figure and major influence on modern homeopathic thought. After travelling to India, Tony returned to teach yoga before beginning his homeopathic practice in 1982. He later studied Transpersonal Psychotherapy with Ian Gordon Brown and, in the mid-'80s, was among the group of students who studied under George Vithoulkas, the world-renowned Greek teacher and practitioner. Tony is known for bringing the Materia Medica to life, weaving his extensive clinical experience into his teaching. He continues to lecture at colleges and conferences worldwide. If you would like to support the Homeopathy Hangout Podcast, please consider making a donation by visiting www.EugenieKruger.com and click the DONATE button at the top of the site. Every donation about $10 will receive a shout-out on a future episode. Learn more about CHE Australia and its homeopathy training programs: https://chehomeopathy.com.au/ Join my Homeopathy Hangout Podcast Facebook community here: https://www.facebook.com/groups/HelloHomies Follow me on Instagram https://www.instagram.com/eugeniekrugerhomeopathy/ Here is the link to my free 30-minute Homeopathy@Home online course: https://www.youtube.com/watch?v=vqBUpxO4pZQ&t=438s Upon completion of the course - and if you live in Australia - you can join my Facebook group for free acute advice (you'll need to answer a couple of questions about the course upon request to join): www.facebook.com/groups/eughom
Dr. Houda Hachad, Vice President of Clinical Operations at Aranscia, highlights the importance of regular medication reviews in an age of growing polypharmacy and advancements in the use of pharmacogenomics to identify potential risks. The key goal is to use the minimal effective dose of a medication and determine which drugs are most effective for treating identified conditions without causing unintended side effects. Adopting a preemptive pharmacogenomic testing approach for patients taking more than 5 drugs is noted as a way to reduce hospital readmissions, emergency room visits, and adverse drug events. Houda explains, "So polypharmacy is becoming more and more common. I think the data shows that up to 40% of adults now take a lot of medications. And polypharmacy is typically defined as the regular use of five medications or more. But in some settings, we're seeing what we call excessive polypharmacy, which is using nine or more." "So there are multiple patient cohorts, as you can imagine, that take these medications, definitely patients in hospital settings, older patients, patients that suffer from behavioral health issues, and any chronic conditions, patients with diabetes, hypertension, and obesity are going to be your typical polypharmacy patients. So our tools, which span genetic testing, medication reviews, and the use of various patient information to provide precision care, allow us to simplify and help doctors mitigate the risks associated with polypharmacy." "Each time you add a medication to a patient, you're increasing the risk of having these adverse drug events. We have tools that can reduce the risk of polypharmacy, including pharmacogenomics." #Aranscia #Polypharmacy, #DrugGeneInteractions #dpydTesting #MedicationSafety #Pharmacogenomics aranscia.com Listen to the podcast here
Dr. Houda Hachad, Vice President of Clinical Operations at Aranscia, highlights the importance of regular medication reviews in an age of growing polypharmacy and advancements in the use of pharmacogenomics to identify potential risks. The key goal is to use the minimal effective dose of a medication and determine which drugs are most effective for treating identified conditions without causing unintended side effects. Adopting a preemptive pharmacogenomic testing approach for patients taking more than 5 drugs is noted as a way to reduce hospital readmissions, emergency room visits, and adverse drug events. Houda explains, "So polypharmacy is becoming more and more common. I think the data shows that up to 40% of adults now take a lot of medications. And polypharmacy is typically defined as the regular use of five medications or more. But in some settings, we're seeing what we call excessive polypharmacy, which is using nine or more." "So there are multiple patient cohorts, as you can imagine, that take these medications, definitely patients in hospital settings, older patients, patients that suffer from behavioral health issues, and any chronic conditions, patients with diabetes, hypertension, and obesity are going to be your typical polypharmacy patients. So our tools, which span genetic testing, medication reviews, and the use of various patient information to provide precision care, allow us to simplify and help doctors mitigate the risks associated with polypharmacy." "Each time you add a medication to a patient, you're increasing the risk of having these adverse drug events. We have tools that can reduce the risk of polypharmacy, including pharmacogenomics." #Aranscia #Polypharmacy, #DrugGeneInteractions #dpydTesting #MedicationSafety #Pharmacogenomics aranscia.com Download the transcript here
What if the fastest way to grow your healthcare organization is to slow down? In this episode of The Disrupted Podcast, Scott Middleton returns from Scotland straight into the thick of a merger — and what he's learning is reshaping how he thinks about change itself. Scott takes us inside the integration of TCPA and Providence Care into Your Health, where two very different models are colliding. One organization built 640 billing codes last year; the other built 40. One puts a single nurse practitioner in a building with no support; the other surrounds providers with nurses and community health workers. The opportunity is enormous — but so is the risk of moving too fast and scaring everyone away. What if the fastest way to grow your healthcare organization is to slow down? In this episode of The Disrupted Podcast, Scott Middleton returns from Scotland straight into the thick of a merger — and what he's learning is reshaping how he thinks about change itself. Scott takes us inside the integration of TCPA and Providence Care into Your Health, where two very different models are colliding. One organization built 640 billing codes last year; the other built 40. One puts a single nurse practitioner in a building with no support; the other surrounds providers with nurses and community health workers. The opportunity is enormous — but so is the risk of moving too fast and scaring everyone away. In this conversation, Jamie and Scott explore: Why a nurse practitioner alone is a "single source of failure" — and how staffing changes everything How to enter a building without threatening the provider they already love Why billing isn't bureaucracy — it's how Medicare knows you made a difference The art of giving people what they think they need now, and the rest over time Advanced care planning, DNRs, and why the right message sometimes needs a different voice This is a masterclass in change management disguised as a healthcare conversation. Listen now — and rethink what "disruption" really requires. Why a nurse practitioner alone is a "single source of failure" — and how staffing changes everything How to enter a building without threatening the provider they already love Why billing isn't bureaucracy — it's how Medicare knows you made a difference The art of giving people what they think they need now, and the rest over time Advanced care planning, DNRs, and why the right message sometimes needs a different voice This is a masterclass in change management disguised as a healthcare conversation. Listen now — and rethink what "disruption" really requires. www.YourHealth.Org
Adverse drug events cause 5-15% of admissions to hospital and drug-drug interactions make up about a fifth of these. Most common are pharmacodynamic situations where two drugs have a similar outcome thereby overdoing the intended outcome. Pharmacokinetic interactions are more complicated to understand as they're more indirect. For example, while medications are cleared by oxidative metabolism in the liver and gut, there are many drugs that interfere with the function of the cytochrome enzymes responsible. This can result in clearance of the first drug at too fast or too slow a rate.Polypharmacy has become more frequent over the decades with more than half of people over the age of 75 on five or more prescriptions. This episode examines some of the systems that have led to current rates of polypharmacy, and strategies for deprescribing safely in a given patient. We're REWINDing it nine years after it was first published to celebrate the career of Professor Ric Day who has just retired after sixty years of service at St Vincent's Hospital, Sydney. He has been a much-appreciated clinician and prolific research academic with several hundred published papers that have been cited more than forty thousand times.Chapters0:50 Prevalence of drug interactions5:52 Pharmacodynamic vs pharmacokinetic interactions 9:25 Cytochrome enzymes17:33 ACE inhibitors and more26:48 Strategies for deprescribingGuests Professor Richard Day AM MBBS, FRACP (St Vincent's Hospital; UNSW),Professor Sarah Hilmer AM PhD FRACP FAAHMS (Royal North Shore Hospital; Kolling Institute/ USyd). ProductionProduced by Mic Cavazzini DPhil. Music courtesy of FreeMusicArchive includes ‘Flying Pea' and ‘Cherry Blossom' by Daddy Scrabble and “Manly Nunn Steps Out” by Doctor Turtle. Music licenced from Epidemic Sound includes ‘Train Ride' (Instrumental) by Alex Kehm and ‘Yellow Leaf' by Autohacker. Image adapted for RACPAdd educational activity to MyCPD as educational activity or visit web page for a transcript and references.Key ReferencesLife-threatening drug interactions: what the physician needs to know [Internal Medicine Journal] Polypharmacy in older people: when should you deprescribe? [Medicine Today]
The Real Truth About Health Free 17 Day Live Online Conference Podcast
Medical surveillance creates dependency and aging is pathologized—Alan and Pam reveal how overtesting and overtreatment erode resilience. #AgingWithAgency #Overmedicalization #HealthFreedom #HealthTalks
Hosts: Ed Jones (Owner of Nutrition World) & Clint Powell A variety of topics all related to living a healthy life Presented by: Nutrition World www.nutritionw.com Broadcasting from the Nooga Dentistry Studio www.noogadentistry.com Production of: Whitfield Media Group www.vitalhealthradio.com Title: Impact of Tennessee Hemp Bill, Discussion of Polypharmacy & Deprescribing with Dr. Curt Dearing [0:00:00] Ed's Media & Product Updates Preview of main topics: Upcoming Tennessee hemp bill and its negative impact on people using hemp for anxiety, pain, and insomnia. Dr. Curt Deering will discuss polypharmacy and deprescribing. Ed's recent appearances on multiple TV outlets (Fox Phoenix & LA, Be Well NY, CBS Detroit). Discussion of testing the AquaTru water filtration system at home as a potential recommendation (microplastics, partial fluoride removal). Mention that peptides are a growing topic; reference to Noel Lawson as go‑to for prescribed peptides [0:10:42] Tennessee Hemp Bill & Hemp Industry Impact Introduces guest: Dwayne Madden, owner of Hemp House, as a respected local expert. As of July 1 in Tennessee: All Delta‑8 products will no longer be available for in‑state sale. Many THCA products and all vape products will be gone from shops. CBD and Delta‑9 edibles will have caps: Max 15 mg per serving. Max 300 mg per package. Dwayne notes: Heavy users (e.g., serious pain/conditions) will need to consume many servings to reach effective doses. Law doesn't limit how many packages a person can buy, so total milligrams aren't truly stopped—just made inconvenient. Dwayne explains regulatory control moved: From Tennessee Department of Agriculture (2017–2023) To the ABC (Alcoholic Beverage Commission) Board. Key impacts: All products must now go through distributors, similar to alcohol. Distributors collect taxes and sit between producers and retailers. Small operators like Dwayne cannot qualify for distributor licenses , so he must pay a distributor to move product from his own lab to his own stores. Ed frames this as “follow the money trail” and a way to crush competition. In Tennessee after July 1: No in‑state online hemp sales. Banned products (Delta‑8, etc.) not criminalized for possession or use, only for sale. Potential Workaround: Consumers can order from out‑of‑state websites (e.g., North Carolina), receive products in Tennessee Money leaves the local economy, hurting Tennessee businesses. Ed and Dwayne suggest alcohol industry is likely threatened because many people are reducing alcohol use by using hemp products instead Dwayne notes: Alcohol sales have declined while hemp sales rose. Regulators appear to be protecting alcohol interests via hemp restrictions. [0:17:41] Federal Regulations & State Opt‑Outs Upcoming federal regulations in November: Expected to be similarly “ugly and nasty” for hemp nationwide. States will have an option to opt out of these federal hemp rules. Tennessee's stance: Governor has stated Tennessee will NOT opt out, so federal restrictions will apply here. Other states (e.g., North Carolina) might opt out, keeping their markets more open. Industry response: Advocacy groups Tennessee Growers Coalition and Hemp Law Group monitor legislation and organize pushback. Some supportive legislators exist, but political drive to reverse current law is limited. Dwayne and Ed distinguish: Reasonable regulation (ID checks, lab tests, dosage clarity, education) vs. A “wipeout/control/takeover” by shifting to ABC and forcing distributor reliance. Dwayne: Says credible local shops (Hemp House, Chattanooga peers like BeeGrity, Snapdragon, etc.) already follow high standards. States this law is not about safety but about control and revenue capture, and will hurt small farmers and businesses. [0:25:55] What Consumers Should Do Before Deadline Practical advice: Stock up now on products that will disappear: Delta‑8 gummies (popular for sleep, anxiety, pain). Other higher‑milligram THC/CBD edibles. Flower and vapes. Hemp House is running clearance sales to move remaining inventory. Dosing notes: Many people do well with ½ Delta‑8 gummy for sleep/anxiety/pain. Some need more or less; staff helps tailor doses for goals. Hemp House will close its North Shore/Tremont Street flagship store by July 1 due to expected sales hit. Remaining Hemp House locations: Ringgold Road (East Ridge) near Spring Creek. Ooltewah by Food City on Lee Highway. Hixson Pike near Workout Anytime and Publix. Broader impact: Other Chattanooga hemp businesses have large staffs (some near 100 employees) and will be heavily affected. The industry is described as grassroots, farmer‑driven, and passionately quality‑focused. [0:33:20] Polypharmacy & Deprescribing with Dr. Curt Dearing Ed introduces Dr. Curt Dearing, clinical pharmacist at Nutrition World (30+ years experience). Curt's background: Formerly fully conventional pharmacist; later “veil lifted” as he discovered green pharmacy (nutritional & botanical alternatives). Current mission: Community outreach to medical schools and residency programs Teach about nutritional and natural alternatives not covered in standard curriculums. Traditional training provides almost zero meaningful nutrition or green pharmacy education. Polypharmacy: use of 5 or more prescription medications. Curt notes: Majority of Americans 65+ meet this definition. Average American receives ~17 prescriptions per year (not all concurrent). Consequences: Increased ER visits due to drug side effects. Estimated ~250,000 deaths/year from drug‑induced causes. Curt's role: Specializes in deprescribing: safely reducing or eliminating unnecessary pharmaceuticals and replacing them with effective natural options when possible. How Curt Works with Patients & Their Doctors Curt provides coaching, not independent prescribing. Creates detailed packets (10–18+ pages) explaining: Why certain drugs may no longer be needed. Evidence for natural alternatives (e.g., supplements, lifestyle changes). Encourages clients to take the packet to their doctor and have an informed discussion. Patients often fear how their doctors will react to attempts to deprescribe. Green Pharmacy Approach (as described by Dr. Curt Dearing) Using nutritional, botanical, and lifestyle-based therapies either instead of or alongside pharmaceuticals. Focusing on root causes and supporting the body's own healing mechanisms, not just pushing lab numbers in a certain direction. Why polypharmacy is a problem: Increases side effects, drug–drug interactions, and emergency room visits. Contributes to cognitive decline, gut problems, and overall worse health. Often leads to the “prescribing cascade”: Drug A causes side effects → a new drug is added for those side effects → more side effects → more drugs, and so on. How Dr. Curt Dearing uses green pharmacy to reduce polypharmacy: Curt creates a comprehensive list of all medications and supplements. Asks: “Why was this started?” and “Is it still needed?” Looks for: Drugs with no clear current indication. Drugs where a natural option can give similar or better benefit with fewer risks. Drugs that can be safely tapered or sometimes stopped outright (always in coordination with the prescriber). Identifies which meds are likely causing the most harm or least benefit. Some drugs require slow, structured tapering (e.g., sleep meds, acid blockers). Others may be candidates for direct discontinuation after medical agreement. Replacing or supporting with natural alternatives ( please note this is not medical advice, this is a discussion of personal examples in collaboration with medical oversight) Cholesterol: Instead of (or in place of some) statin use, Curt uses berberine and bergamot (Berbercol). In Ed's brother's case, his cholesterol numbers improved on green-pharmacy options, matching or exceeding statin outcomes without the same side‑effect burden. Pain & inflammation: Uses curcumin (for most people), and Boswellia when curcumin isn't enough. Gut/acid issues: Long-term proton pump inhibitor (PPI) use (e.g., omeprazole, lansoprazole) is flagged as harmful to gut microbiome and nutrient absorption. Curt builds step-down plans (tapering PPIs) while supporting the gut with natural measures instead of leaving people on a PPI for 30 years. Focus on side benefits, not side effects. Green pharmacy interventions are chosen because they: Address root causes (e.g., metabolic health, inflammation, gut integrity). Often have multiple positive effects (e.g., berberine helping blood sugar and lipids; curcumin helping joints and systemic inflammation). The aim is fewer total drugs, fewer side effects, better overall function. Clients are encouraged to work with their doctor, so deprescribing is: Planned, Monitored, and Integrated with their existing care. Curt and Ed both acknowledge there are situations where “rescue medicine” is necessary: Severe pain where an opioid is appropriate. Acute crises where drugs are needed as a bandage. The green pharmacy view: Use those drugs as short‑term tools, Then remove or reduce them once the immediate crisis passes, While implementing natural strategies to decrease the need for long‑term prescriptions. [0:56:26] Final Segment At‑home HPV testing for cervical cancer Ed explains HPV is a major driver of cervical cancer Historically, women had to schedule an in‑office visit for cervical screening, which creates barriers (cost, fear, time, discomfort, lack of insurance). He notes there is now an option for at‑home HPV testing for cervical screening. Intended to increase access for women who aren't getting regular screening. Ed strongly approves of this as a valuable preventive tool and encourages women who haven't been tested to consider it. Ed cites new data showing: Microplastics are found in 100% of human stool samples tested in one study. Higher levels of microplastics are now being linked to gallstones. Broader concerns: Everyday plastic exposure (especially with food and drink) means these particles can: Interact with cells, Drive inflammation, Contribute to premature cellular aging and reduced energy. Practical countermeasures he recommends: Avoid heating food in plastic or placing hot food into plastic containers/wrap (e.g., Saran wrap, plastic take‑out containers). Filter drinking water to remove microplastics (he's trialing the AquaTru system at home, which he says removes 100% of microplastics and much of the fluoride). Improve indoor air quality to reduce airborne microplastic exposure. Ed highlights a serious, long‑term job opening at Nutrition World: Not a summer or short‑term job. Best for someone philosophically aligned with healthy eating and the “green pharmacy” approach. Interested candidates should: Go into the store and speak with Scott, Elisha, or Matt and complete an application. The post Radio Show / Podcast – May 31, 2026 first appeared on Vital Health Radio.
Around a third of patients with dementia remain undiagnosed. Dr Alistair Robertson, a GP with an extended role in frailty, provides insights for GPs and other primary care professionals on how they can address underdiagnosis and provide support for patients and their families. He covers signs and symptoms to look out for, assessments to conduct, the role of drug treatments, and the benefits of honest conversations with patients and families.Educational objectivesAfter listening to this podcast, healthcare professionals should be better able to:Consider the number of patients in their practice who may have undiagnosed dementiaReflect on differential diagnoses and how to take a good historyRecall key signs and symptoms to look out for and how these may differ in different types of dementiaUnderstand the role of cognitive assessment tools and how to use themReview current drug treatments and their effectivenessExplore how to address polypharmacyUnderstand the importance of early, honest conversations with patients and familiesYou can access the website version of this podcast, along with a list of key learning points and downloadable notes written by Dr Robertson, on MIMS Learning. MIMS Learning offers hundreds of hours of CPD for healthcare professionals, along with a handy CPD organiser and note-taking for appraisal.Please note: this podcast is presented by medical editors and discusses educational content written or presented by doctors, nurses and other healthcare professionals on the MIMS Learning website and at live events.MIMS LearningRegister for a FREE accountRelated resources from MIMS Learning and MIMSPractical advice for GPs on dementia document created by Dr Alistair Robertson.Frailty: clinical reviewGuidance update: SIGN guidelines for support of people with dementia and their carersPolypharmacy in a patient with dementia: nursing home case studyAnticholinergic cognitive burden (ACB) scores for commonly used drugs Hosted on Acast. See acast.com/privacy for more information.
The Real Truth About Health Free 17 Day Live Online Conference Podcast
Statin use in the elderly, push for PCSK9 drugs, and pressures on clinicians show how economic interests shape patient care. #StatinsAndSeniors #PCSK9 #DrugMarketing #HealthTalks
What if every "non-compliant" patient was actually a signal that the system isn't working for them? In this episode, Jamie sits down with Jaclyn Taylor, Clinical Strategy Director at Your Health and a nurse practitioner who started her career as a home-based provider in 2020 — thrown straight into the fire of COVID, isolated patients, and a healthcare world rewriting itself in real time. What she saw inside patients' homes — medications scattered on tables, food insecurity, missing transportation — changed how she thinks about every chart she's ever read. You'll hear: Why a nurse-first pathway gives nurse practitioners a fundamentally different lens than a medical school pathway — and why patients feel it What working across home care, telehealth, trauma, and wellness teaches you about treating the whole human, not just the diagnosis Why trauma surgery turned Jacqueline into a believer in proactive, longitudinal care — and what gets missed when we only meet patients after something has already gone wrong The two words she uses to describe what's most broken in traditional healthcare: fragmentation and misalignment How empathy stops being a poster and starts being operational — built into the design of care itself If you've ever felt invisible inside the healthcare system, or if you're the one trying to fix it, this conversation reframes the whole game. Press play. www.YourHealth.Org
In 1976, Merck's CEO told Fortune magazine his dream was to make drugs for healthy people and sell them to everyone. Fifty years later, that dream is the air we breathe.In this solo episode, Dr. Roger McFillin traces how a generation was taught that being human is a disease. He walks through the 1994 inflection point, the Zoloft commercial that rewrote a culture, the academics and journals and sales reps who built the influence machine, and the school-to-pediatrician-to-customer-for-life pipeline that captured childhood itself.He reflects on the recent HHS mental health summit, what it gets right, and what the bureaucrats are still unwilling to say out loud. He names what was lost in the trade. The wisdom passed down through generations. The understanding that emotions are a guidance system, not a malfunction.The mental health industrial complex is not a healthcare system. It's a control system. The drugs are weapons. The diagnoses are chains.This is how you walk out of the cage.
In Episode 117 of Strange, Rare, and Peculiar, Denise Straiges and Alastair Gray answer listener questions about what happens when homeopathic principles meet real-life complexity.They take on polypharmacy in emergency situations, veterinary homeopathy with traumatized rescue dogs, and the harder question many people quietly carry: What if I've tried homeopathy—and nothing changed?Get your Organon out for this one. Denise and Alastair discuss Aphorisms 148 and 260, exploring what Hahnemann had to say about the labor of true homeopathic practice, obstacles to cure, and why homeopathy asks for more than shortcuts.In this episode:When, if ever, more than one remedy makes senseHomeopathy for animals in acute stressWhy “nothing happened” may not always mean nothing happenedObstacles to cure and case managementHahnemann, roasted pigeons, and the work homeopathy requiresStrange, Rare & Peculiar is a weekly podcast with Denise Straiges and Alastair Gray of the Institute for the Advancement of Homeopathy and the Academy of Homeopathy Education.This season, we're focusing on truth — what it means to Aude Sapere (“dare to know”) in homeopathy today. From Hahnemann's original insights to the realities of modern practice, research, and education, Denise and Alastair bring over 50 years of experience to conversations that challenge assumptions and invite curiosity.
In this episode of Walk Don't Run to the Doctor, Dr. Miles Hassell discusses the growing problem of polypharmacy — taking too many medications at once — and why it can create serious health risks, especially for older adults. Dr. Hassell explains how medication "cascades" happen, why many drug combinations are never actually studied for safety, and how lifestyle changes can often reduce the need for prescriptions. Through real patient stories, including an 80-year-old woman whose independence was restored after reducing unnecessary medications, this episode highlights the importance of reviewing prescriptions carefully, coordinating care between providers, and focusing on long-term health through lifestyle medicine. Key Takeaways: Why taking 5+ medications can increase the risk of falls, memory issues, and loss of independence How "polypharmacy cascades" lead to more prescriptions and more side effects The importance of reviewing all medications with your doctor and pharmacist What the Beers List is and why older adults should know about it How exercise, nutrition, and weight loss can sometimes reduce the need for medications Why using a single pharmacy can help catch dangerous drug interactions Get your copy of Good Food Great Medicine, 4th ed.: https://a.co/d/1D6hIYM More references can be found at www.GreatMed.org Would you like Dr. Hassell to answer your question on the air? Contact us! Write us a letter, We love to hear from you! Send questions, comments, and support to: GreatMed.org Phone/text: 503-773-0770 e-mail: info@GreatMed.org EIN: 88-326-7056 4804 NW Bethany Blvd., Suite I-2, #273 Portland OR 97229 #Polypharmacy #LifestyleMedicine #HealthyAging #MedicationSafety #DrMilesHassell #WalkDontRunToTheDoctor
Real Life Pharmacology - Pharmacology Education for Health Care Professionals
Polypharmacy is one of the most common—and often overlooked—challenges in modern healthcare, especially in older adults. It's not just about the number of medications a patient is taking, but whether each one still has a clear indication, is providing benefit, and isn't causing harm. As medication lists grow, so does the risk of adverse effects, drug interactions, and something we see all the time in practice: the prescribing cascade. A prescribing cascade happens when a medication causes a side effect that is misinterpreted as a new medical condition, leading to the addition of another drug. Over time, this can snowball into unnecessary complexity and increased risk for patients. In part 2 of this podcast, we outline 5 more examples that I’ve encountered in my geriatric pharmacist practice. Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE! Support The Podcast and Check Out These Amazing Resources! NAPLEX Study Materials BCPS Study Materials BCACP Study Materials BCGP Study Materials BCMTMS Study Materials Meded101 Guide to Nursing Pharmacology (Amazon Highly Rated) Guide to Drug Food Interactions (Amazon Best Seller) Pharmacy Technician Study Guide by Meded101
A discussion on the concepts of weight-inclusive care and healthismSome comments on medicine's biggest failures
#209 - The #1 Symptom of Hidden Toxin Overload At a certain point, it's not one thing. It's the accumulation. And most of it isn't obvious in the moment. It's what builds quietly over time. Because it's one thing to understand toxic load. It's another to see how it actually plays out inside the body day to day. In Part 2, I sit back down with Dr. Joe Nieusma, toxicologist with nearly four decades of experience, and we go deeper into what's actually happening inside the body when inflammation, exposure, and intervention start to overlap. And this is where the nuance matters. Inflammation isn't just something to suppress. It's how your body heals. But when it runs unchecked, or when the body doesn't have what it needs to regulate it, that's when things start to spiral. We talk about the fine line between helpful inflammation and when it tips into something far more damaging, and why trying to shut it down completely can actually work against you. There's also a moment in this conversation that really sticks. The idea that your body is constantly redistributing and compensating under stress, and that what shows up on a lab or in a moment doesn't always tell the full story. Which explains a lot more than you'd think. We also get into something that doesn't get talked about enough. How people end up on multiple medications that start to interact, stack, and create entirely new problems. Not because anyone is doing anything wrong, but because nothing in the body happens in isolation. And once you see that, it becomes a very different conversation. We also go into real-world examples, from low-level chemical exposure that shows up years later, to how everyday foods and environmental inputs can quietly drive inflammation in ways most people never connect. And one of the biggest takeaways from this entire conversation: your body is always trying to move toward balance. The question is whether we're supporting that or unknowingly working against it. 00:00 Why this needed a Part 2 and where we're going deeper. 02:00 The truth about inflammation and why suppressing it isn't always the answer. 05:00 What happens in the body during stress and why lab values don't tell the full story. 10:00 Low-level exposure over time and how it quietly impacts long-term health. 18:30 Polypharmacy and how medications can start creating new problems. 26:00 The toxic cocktail effect and why symptoms often stack instead of resolve. 28:30 Finding root cause and why removing the trigger can change everything. If something in this episode clicked, take a few minutes and write this down: Where might my body be dealing with more than I've been aware of? Nothing you need to do yet. Just something to start paying attention to. If you don't yet have the Morning Mindset Journal, that's a great place to keep reflections like this. It's free and linked in the show notes.❤️ If this episode shifted how you're thinking about your health, send it to someone who's been trying everything and still not getting answers. And if you're not already following the show, make sure you hit follow. Part 2 is where this conversation starts to turn into something you can actually apply. If something clicked for you, I'd love to hear that too. Leave a review or share it and tag me so I can see what landed.
Alan gets candid about the "aging practice" and the sobering clinical hurdles of geriatric dentistry. As both he and his long-term patients cross major milestones, Alan explores the dangerous intersection of polypharmacy, xerostomia, and the "comfort food" trap of sugary hard candies. The discussion dives deep into why the dental "ratchet" only turns one way, the necessity of shifting toward more aggressive, proactive treatment planning for patients over 65, and the complex surgical risks posed by bisphosphonate therapy. It's a heartfelt look at the frustration of watching health decline and a call to action for clinicians to adapt their verbal skills and protocols to better serve their patients in the home stretch. Join the Very Dental Facebook Group using one of these passwords: Timmerman, Paul, Bioclear, Hornbrook, Gary, McWethy, Papa Randy, Frank or Lipscomb! The Very Dental Podcast network is and will remain free to download. If you'd like to support the shows you love at Very Dental then show a little love to the people that support us! We're proud to be supported by the folks at Net32! I'm a big fan of the Bioclear Method! I think you should give it a try and I've got a great offer to help you get on board! Use the exclusive Very Dental Podcast code VERYDENTAL8TON for 15% OFF your total Bioclear purchase, including Core Anterior and Posterior Four day courses, Black Triangle Certification, and all Bioclear products. Crazy Dental has everything you need from cotton rolls to equipment and everything in between and the best prices you'll find anywhere! If you head over to verydentalpodcast.com/crazy and use coupon code "VERYSHIP" you'll get free shipping on your order! Go save yourself some money and support the show all at the same time! The Wonderist Agency is basically a one stop shop for marketing your practice and your brand. From logo redesign to a full service marketing plan, the folks at Wonderist have you covered! Go check them out at verydentalpodcast.com/wonderist! Enova Illumination makes the very best in loupes and headlights, including their new ergonomic angled prism loupes! They also distribute loupe mounted cameras and even the amazing line of Zumax microscopes! If you want to help out the podcast while upping your magnification and headlight game, you need to head over to verydentalpodcast.com/enova to see their whole line of products! CAD-Ray offers the best service on a wide variety of digital scanners, printers, mills and even their very own browser based design software, Clinux! CAD-Ray has been a huge supporter of the Very Dental Podcast Network and I can tell you that you'll get no better service on everything digital dentistry than the folks from CAD-Ray. Go check them out at verydentalpodcast.com/CADRay!
What if the people case-managing your care had a financial reason to keep you sicker? That's the uncomfortable question Scott Middleton puts on the table in this episode — recorded live from the American Case Managers Conference in Orlando, where Scott went to learn, and ended up being told Your Health didn't "fit" because they weren't a hospital. Jamie and Scott unpack what the nurse case manager role actually looks like at Your Health — and why moving case management out of hospitals and into patients' homes isn't just better care, it's better economics. Scott shares the research proving the model works: 50% reduction in Medicare spend when patients are seen at the right frequency by the right people. In this episode: Why hospitalists may be "the demise of the American healthcare system" The difference between nurse practitioners (diagnose and treat) and nurse case managers (assess and guide) — and why blurring them costs patients The 16.05-visits-per-risk-point model David Clemens' research validated How coding departments are quietly diagnosing patients with diseases they don't have Why Medicare's 6-year insolvency window may be the disruption we need Head-to-toe assessments, delegation rights, and the real job of an RN in the home If you've ever suspected the system is working exactly as designed — just not for the patient — press play. www.YourHealth.Org
Real Life Pharmacology - Pharmacology Education for Health Care Professionals
Polypharmacy isn't just about medication count—it's about cumulative risk and unintended consequences. One of the biggest drivers is the prescribing cascade, where a drug side effect is mistaken for a new condition, and another medication gets added instead of addressing the root cause. You see this all the time in practice. A patient starts amlodipine and develops edema, then gets placed on furosemide. Or donepezil leads to urinary symptoms, and oxybutynin is added—potentially worsening cognition. These patterns add risk quickly. In this episode, I’ll break down common examples that I have recently encountered in practice. Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE! Support The Podcast and Check Out These Amazing Resources! NAPLEX Study Materials BCPS Study Materials BCACP Study Materials BCGP Study Materials BCMTMS Study Materials Meded101 Guide to Nursing Pharmacology (Amazon Highly Rated) Guide to Drug Food Interactions (Amazon Best Seller) Pharmacy Technician Study Guide by Meded101
This week, Bobbi Conner talks with MUSC's Dr. Gregory Fear about the issues and challenges of polypharmacy in the older adult years.
If you've ever sat in a doctor's office describing brain fog, mood swings, terrible sleep, and a body that no longer responds to anything you try — only to be sent home with a shrug and maybe an antidepressant — this one's for you. Dr. Mary Claire Haver, Board-Certified OBGYN and Certified Menopause Specialist, is back for round two, and she came prepared. In this episode, she breaks down the hormonal wildfire she calls 'The Zone of Chaos,' explains why perimenopause looks nothing like what your doctor was trained to treat, and gives you the actual language to walk into your next appointment and finally get some answers. Buckle up. Episode Overview (timestamps are approximate): (0:00) Intro/Teaser (5:00) The Zone of Chaos (9:00) How Do You Know You're in Perimenopause? (13:00) "I Don't Feel Like Myself" - The Universal Symptom (15:00) 10 Doctors, Polypharmacy & a Hysterectomy (17:00) How to Get Answers (19:00) Your Brain on Perimenopause (23:00) The ADHD Connection (26:00) Bone Density & Muscle Mass (29:00) Calming the Chaos, Not Replacing What's Lost (44:00) What Mary Claire Actually Does (53:00) Fasting, Menowashing & Your Bull$h!t Radar (56:00) A Letter to My 35-Year-Old Self (1:00:00) After Party: Dr. Stephanie's Takeaways Resources mentioned in this episode: https://drstephanieestima.com/podcasts/ep462/ We couldn't do it without our sponsors: ONESKIN - Harness the power of peptides for fuller hair and glowing skin. Save 15% at https://oneskin.co/better with code BETTER. APOLLO - The Apollo wearable supports energy, focus, relaxation, and sleep by syncing with your rhythms. Go to https://ApolloNeuro.com/BETTER to get $99 off Apollo with Smart Vibes AI. LMNT - Stay hydrated without the sugar, food dye, and other dodgy ingredients found in popular electrolyte and sports drinks. Receive a free LMNT Sample Pack with any order when you make a purchase at https://DrinkLMNT.com/Better BIOPTIMIZERS - Magnesium Breakthrough contains multiple types of magnesium plus cofactors like B6 to enhance absorption. Visit https://bioptimizers.com/better and use code BETTER to save 15%. ****************************P.S. When you're ready, here are two ways Dr. Stephanie can help you:Subscribe: The Mini Pause — My weekly newsletter packed with the most actionable, evidence-based tools for women 40+ to thrive in midlife.Build Muscle: LIFT — My progressive strength training program designed for women in midlife. Form-focused, joint-friendly, and built for real results. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Send us Fan MailIn this week's episode of the Holy Health Podcast, we explore the powerful intersection of medicine and Torah. Dr. Jonathan Weisen joins us to unpack polypharmacy - why so many people today are taking multiple medications, the potential risks, and how patients can have smarter conversations with their doctors about simplifying care.Then Rabbi Peretz Segal brings a meaningful Torah perspective, offering insights that deepen how we think about health, responsibility, and balance in our lives.It's a thoughtful conversation that blends modern medicine with timeless wisdom.- - - - - YouTube: https://youtu.be/7hZCNqVR99Q- - - - - Links:Dr. Jonathan Wiesen -Website: https://mediorbis.com/LinkedIn Profile: https://www.linkedin.com/in/jonathan-wiesen--b7646417?utm_source=share_via&utm_content=profile&utm_medium=member_androidRabbi Peretz Segal -Website: https://www.mindmovers.org/aboutLinkedIn Profile: https://www.linkedin.com/in/peretz-segal?utm_source=share_via&utm_content=profile&utm_medium=member_android- - - - - Holy Health Podcast:Email: Holyhealthpodcast@gmail.comInstagram: @holy_healthpodcastwwwwHolyhealthpodcast.comHoly Health Official Podcast:https://www.buzzsprout.com/589555/9876240Holy Health YouTube Account:https://www.youtube.com/channel/UCrYPOvFawrjhH_2U7r61M2QMusach Haguf:Instagram: @darapt613@holy_healthpodcast- - - - -This podcast has been edited by Yakir Abelow of 'YA Joker productions'For more information contact:https://wa.me/c/972586918089Instagram: https://www.instagram.com/yakir_abelow_photography/
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-475 Overview: A prescribing cascade occurs when adverse effects of a medication are mistaken for a new condition and treated with additional drugs. Older adults experiencing polypharmacy are most at risk. The impact of prescribing cascades can be substantial, leading to falls, organ injury, unnecessary imaging and tests, and more. Join us as we explore how to recognize and prevent these harmful cascades in your patients. Episode resource links: Adrien O, Mohammad AK, Hugtenburg JG, et al. Prescribing cascades with recommendations to prevent or reverse them: a systematic review. Drugs Aging. 2023;40(12):1085-1100. doi:10.1007/s40266-023-01072-yPubMedGoogle ScholarCrossref Brath H, Mehta N, Savage RD, et al. What is known about preventing, detecting, and reversing prescribing cascades: a scoping review. J Am Geriatr Soc. 2018;66(11):2079-2085. doi:10.1111/jgs.15543PubMedGoogle ScholarCrossref Daunt R, McGettigan S, Kelly L, Curtin D, O'Mahony D. Detection of Potential Prescribing Cascades in Multimorbid Older Patients Hospitalised with Acute Illness-An Observational Prospective Prevalence Study. Drugs Aging. 2025;42(6):535-546. doi:10.1007/s40266-025-01201-9 Growdon ME, Tjota N, Campbell R, et al. Decision-Making and Downstream Outcomes of the Gabapentinoid-Diuretic Prescribing Cascade. JAMA Netw Open. 2025;8(12):e2545274. doi:10.1001/jamanetworkopen.2025.45274 McCarthy LM, Savage R, Dalton K, et al. ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people. Drugs Aging. 2022;39(10):829-840. doi:10.1007/s40266-022-00964-9PubMedGoogle ScholarCrossref O'Mahony, D., Cherubini, A., Guiteras, A.R. et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med 14, 625–632 (2023). https://doi.org/10.1007/s41999-023-00777-y Rochon, P.A., O'Mahony, D., Cherubini, A. et al. International expert panel's potentially inappropriate prescribing cascades (PIPC) list. Eur Geriatr Med 16, 1573–1584 (2025). https://doi.org/10.1007/s41999-025-01215-x Young EH, Pan S, Yap AG, Reveles KR, Bhakta K. Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016. PLoS One. 2021;16(8):e0255642. Published 2021 Aug 3. doi:10.1371/journal.pone.0255642 Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-475 Overview: A prescribing cascade occurs when adverse effects of a medication are mistaken for a new condition and treated with additional drugs. Older adults experiencing polypharmacy are most at risk. The impact of prescribing cascades can be substantial, leading to falls, organ injury, unnecessary imaging and tests, and more. Join us as we explore how to recognize and prevent these harmful cascades in your patients. Episode resource links: Adrien O, Mohammad AK, Hugtenburg JG, et al. Prescribing cascades with recommendations to prevent or reverse them: a systematic review. Drugs Aging. 2023;40(12):1085-1100. doi:10.1007/s40266-023-01072-yPubMedGoogle ScholarCrossref Brath H, Mehta N, Savage RD, et al. What is known about preventing, detecting, and reversing prescribing cascades: a scoping review. J Am Geriatr Soc. 2018;66(11):2079-2085. doi:10.1111/jgs.15543PubMedGoogle ScholarCrossref Daunt R, McGettigan S, Kelly L, Curtin D, O'Mahony D. Detection of Potential Prescribing Cascades in Multimorbid Older Patients Hospitalised with Acute Illness-An Observational Prospective Prevalence Study. Drugs Aging. 2025;42(6):535-546. doi:10.1007/s40266-025-01201-9 Growdon ME, Tjota N, Campbell R, et al. Decision-Making and Downstream Outcomes of the Gabapentinoid-Diuretic Prescribing Cascade. JAMA Netw Open. 2025;8(12):e2545274. doi:10.1001/jamanetworkopen.2025.45274 McCarthy LM, Savage R, Dalton K, et al. ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people. Drugs Aging. 2022;39(10):829-840. doi:10.1007/s40266-022-00964-9PubMedGoogle ScholarCrossref O'Mahony, D., Cherubini, A., Guiteras, A.R. et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med 14, 625–632 (2023). https://doi.org/10.1007/s41999-023-00777-y Rochon, P.A., O'Mahony, D., Cherubini, A. et al. International expert panel's potentially inappropriate prescribing cascades (PIPC) list. Eur Geriatr Med 16, 1573–1584 (2025). https://doi.org/10.1007/s41999-025-01215-x Young EH, Pan S, Yap AG, Reveles KR, Bhakta K. Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016. PLoS One. 2021;16(8):e0255642. Published 2021 Aug 3. doi:10.1371/journal.pone.0255642 Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
The Real Truth About Health Free 17 Day Live Online Conference Podcast
The panel opens with credentials clarification and personal stories highlighting how U.S. medicine prioritizes drugs over lifestyle solutions. #MedicalReform #PillCulture #LifestyleMedicine #HealthTalks
Stephen and Jonathan delve into various health topics, focusing on the implications of statin use, the importance of understanding blood test results, and the challenges of navigating healthcare systems. They discuss the role of diet, particularly the carnivore diet, in managing health conditions, and the significance of supplements. The conversation also touches on the complexities of blood pressure management, dietary guidelines in hospitals, and the potential risks associated with high-fat consumption. Overall, the discussion emphasises a holistic approach to health, advocating for understanding root causes rather than relying solely on medications.Chapters00:00 Introduction to Health Conversations01:20 The Statins Debate and Misreported Studies04:32 Polypharmacy and Root Cause Analysis09:28 Understanding Blood Test Results11:54 Experiences with Healthcare Systems15:24 Dietary Guidelines and Hospital Food17:54 Interpreting Blood Metrics19:12 The Role of Supplements in Health20:12 Blood Pressure and Health Indicators22:09 Managing High Blood Pressure27:00 Fat Adaptation and Gallbladder Health29:57 Water Fasting and Dietary Discipline30:52 Constipation and Dietary Adjustments34:23 Postprandial Insulin Response36:58 Carnivore Diet and Polycythemia41:42 Fat Consumption and Diabetes Risk45:51 Potassium Iodide Supplementation
When Laura Delano was just 14 years old, a single psychiatric appointment set her on a 14-year path of diagnoses, medications, and a belief that her brain was permanently broken. In this conversation, the author of Unshrunk shares how treatment that initially promised relief gradually led to dependency, identity loss, and despair — and how questioning that narrative changed the course of her life.Laura and Leslie explore what real informed consent in mental health care should look like, why patients and doctors often lack full information, and how diagnoses and polypharmacy can shape — and sometimes distort — a person's understanding of themselves. This episode isn't anti-medication; it's pro-information, pro-agency, and pro-humanity — an invitation to think more deeply about mental health, healing, and the power of informed choice.Hosted on Ausha. See ausha.co/privacy-policy for more information.
In this episode of Your Health University, Jamie sits down with Dr. Jimmie Williamson, Chief Behavioral Health Officer at Your Health, to break down why behavioral health belongs inside primary care—not outside it. Jimmie explains how telehealth lowered stigma, how mental health diagnoses (“F codes”) often correlate with frequent ER use, and why Your Health moved from intuition to data-driven referral models using tools like Power BI. They also map the full behavioral health ecosystem—from psych nurse practitioners to therapists to the psych pharmacist—and clarify when and how teams should refer patients for the right level of support. The takeaway is simple: earlier behavioral health intervention can improve lives, reduce hospital visits, and strengthen value-based care outcomes system-wide. www.YourHealth.Org
In this week's episode of Medicine: The Truth, hosts Dr. Robert Pearl and Jeremy Corr look closely at the stories and controversies shaping U.S. healthcare at the start of 2026. From a severe flu season and resurgent vaccine-preventable diseases to drug pricing, autism research and the growing role of AI in medicine, the episode offers a data-driven look at where American healthcare is headed. The show opens with warnings about infectious disease. A dangerous H3N2 flu strain is driving hospitalizations, particularly among children, while measles and whooping cough outbreaks continue to spread among unvaccinated populations. To Dr. Pearl, these trends do not appear random. They reflect falling vaccination rates, weakened public-health messaging and growing political interference at federal agencies tasked with protecting the public. From there, the conversation turns to vaccine policy itself. Recent changes at the CDC (including a sharply reduced childhood vaccine schedule and new recommendations against universal newborn hepatitis B vaccination) raise serious concerns. Pearl explains why comparisons to countries like Denmark (with its reduced vaccine schedule) are deeply misleading, and why abandoning universal vaccination in a fragmented U.S. healthcare system risks reversing decades of progress. Here's a look at other must-know stories from this episode of Medicine: The Truth: Positive vaccine evidence: New CDC data show significant reductions in emergency visits among children who received COVID vaccines, reinforcing their safety and effectiveness. Pandemic lessons for children: Pediatric obesity rose during COVID lockdowns, while mental health outcomes improved after schools reopened, underscoring the tradeoffs of prolonged closures. Drug pricing deals with manufacturers: The administration's agreements with pharmaceutical companies apply narrowly to government purchases and exclude many high-cost drugs, limiting their overall impact. First oral GLP-1 approved: The FDA cleared the first pill version of a GLP-1 weight-loss drug, offering convenience but likely remaining unaffordable until prices fall closer to $200 per month. Autism research update: Rising autism prevalence is driven largely by broader diagnostic criteria and awareness. Large studies continue to show no link to vaccines or acetaminophen, while new research points to strong genetic factors and distinct autism subtypes. ACA exchange subsidy uncertainty: Congress has yet to prevent looming premium increases for millions of exchange enrollees. Pearl argues for avoiding coverage cliffs and capping household contributions as a share of income. Polypharmacy in seniors: One in eight Medicare Part D beneficiaries now takes eight or more medications, increasing the risk of side effects, falls and hospitalizations in a fragmented system. New dietary guidelines: Federal recommendations now emphasize animal protein alongside stronger warnings against sugar and ultra-processed foods, a shift that may conflict with earlier public-health messaging. AI's expanding role in healthcare: OpenAI's tools increasingly integrate health data from electronic records and consumer apps, signaling how quickly generative AI is becoming part of medical decision-making. Medicare and AI oversight: Traditional Medicare is moving toward AI-assisted prior authorization for certain procedures, a response to fraud and low-value care that Pearl says is inevitable as costs continue to rise. Tune in to Medicine: The Truth for more fact-based coverage and analysis of healthcare's biggest stories. * * * Dr. Robert Pearl is the author of the new book “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” about the impact of AI on the future of medicine. Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify, Stitcher or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn. The post MTT #102: Vaccines under fire, rising disease & the cost of politics in medicine appeared first on Fixing Healthcare.
Top stories of 2025Does the use of statins lead to muscle loss?I have mitral valve prolapse with regurgitation. Should I increase my supplement dosages?
Could you discuss GABA for insomnia and sleep support? Are there long-term health benefits?What impact does a cocktail of pharmaceutical drugs have on the microbiome?Can I take more than 2 daily doses of Dr. Ohira's probiotics?Which is the correct estrogen to take in HRT? Estriol or estradiol?In light of the recent EPA proposal to double permissible formaldehyde emissions, how does this jibe with MAHA?
Is your combination of medications increasing your fall risk? Learn about the rising epidemic of deaths related to falls, and what you can do for prevention in this episode: https://bit.ly/4q1EpqfFalls are one of the most underestimated health crises facing older adults today—and the numbers are staggering. More than 41,000 Americans over age 65 died from falls in 2023. That's more than breast cancer, prostate cancer, car crashes, and overdoses combined. And yet, most of us still think of falls as "bad luck" or "just part of aging."We're not just talking about fall prevention. We're talking about injury prevention, mobility, safer aging, and adding healthy years to your life. If you want to stay independent, upright, and living the life you love, this episode is essential listening. #FallPrevention #FallRisk #SeniorHeath #Aging #AgingSafely #Overmedication #MedicationReview #ElderExercise #TaiChi #EveryoneDiesThePodcast #EveryDayIsAGift In This Episode:03:10 - Are Prescription Drugs Causing the Epidemic of Fatal Falls?08:36 – Movie Review: “The Apprentice”11:01 – Recipe of the Week: Brownie Cookies13:40 – The Importance of a Will22:38 - Understanding Fall Risk and Consequences of a Fall24:09 - Causes of Falls: Intrinsic and Extrinsic Factors25:58 - Causes of Falls: Situational Factors33:01 – What You Can Do To Prevent a Fall47:14 – “Fear” – A Poem by Kahlil Gabran49:11 – OutroSupport the showGet show notes and resources at our website: every1dies.org. Facebook | Instagram | YouTube | mail@every1dies.org
In this episode, Dr. Kharrazian dives into the complex world of mood disorders, shining a light on why conditions like depression and anxiety have become such significant global health challenges. He questions the mainstream approach to treating mood disorders, revealing the limitations and biases present in antidepressant research and the pharmaceutical industry's influence on published data.Dr. Kharrazian explores what's truly happening in the brains of those suffering from chronic mood issues, moving beyond the conventional neurotransmitter model to focus on the importance of neuronal health and plasticity. He breaks down the latest findings on treatments like ketamine, the real risks and shortcomings of long-term antidepressant use, and the many underlying biological factors—from neuroinflammation to neurodegeneration—that practitioners need to consider.Enroll in the complete master class: Mood and Anxiety Disorders Clinical Strategies and Treatment Applications with Dr. Datis Kharrazian at: https://pages.kharrazianinstitute.com/mood-and-anxiety-disordersFor patient-oriented functional medicine courses, visit https://drknews.com/online-courses/For practitioner functional medicine certification courses, visit https://kharrazianinstitute.com/For Certified Functional Nutrition education for both practitioners and lay people, visit https://afnlm.com/00:00 "Anxiety Meds: Benefits and Concerns"03:27 Placebo Effect Outperforms Antidepressants08:33 "Antidepressant Trial Reporting Bias"10:09 "Long-Term Antidepressant Effectiveness Questioned"14:43 Depression: Beyond Neurotransmitter Issues18:06 Mood Disorders: Causes and Approaches21:45 "Functional Medicine & Health Education"Support this show http://supporter.acast.com/solving-the-puzzle-with-dr-datis-kharrazian. Hosted on Acast. See acast.com/privacy for more information.
In this episode of Walk, Don't Run to the Doctor, we take a deep dive into statins, their true benefits, their real risks, and the massive role lifestyle plays in shaping heart disease outcomes. Rather than accepting oversimplified medical advice, this episode empowers you to think critically, understand uncertainty in medicine, and make fully informed decisions about your own health. You'll learn how to interpret risk statistics (like relative vs absolute risk), why lifestyle may outperform medication for many people, and why statins are helpful for some—yet potentially unnecessary or harmful for others. If you've ever been told "your cholesterol is high, you need a statin," this episode will give you the tools to ask better questions and understand whether that advice truly applies to someone like you. Key Takeaways: -Medical uncertainty is real — many "facts" are actually opinions without solid or applicable evidence. -Statins help some people more than others: -Strong evidence for people who already had a heart attack. -Much smaller benefit (sometimes minimal) for healthy, active people without prior heart disease. -Absolute vs. relative risk matters: -A "25% reduction in risk" may really mean only 1 fewer event per 100 people. -Lifestyle changes can reduce risk by 50–80%, often outperforming statin benefits—especially for people who exercise, eat whole foods, avoid smoking, keep weight down, and drink moderately. -Statin risks are real: Muscle pain: up to 1 in 10 Diabetes risk increased: about 1 in 200 Possible cognitive impairment (enough for an FDA warning) Polypharmacy (multiple medications) increases uncertainty and side-effect risks. Get your copy of Good Food Great Medicine, 4th ed.: https://a.co/d/1D6hIYM More references can be found at www.GreatMed.org Would you like Dr. Hassell to answer your question on the air? Contact us! Phone/text: 503-773-0770 e-mail: info@GreatMed.org EIN: 88-326-7056 Write us a letter. We love to hear from you. This podcast is sponsored by our generous listeners. Send questions, comments, and support to: GreatMed.org 4804 NW Bethany Blvd., Suite I-2, #273 Portland OR 97229 Check out this video on Completely Rethinking the Link Between Statins, Cholesterol, & Heart Disease, w/ Dr. Aseem Malhotra: https://www.youtube.com/watch?v=-RU3Ouxt1vs&t=251s References from today's podcast: Ioannidis J. P. (2005). Why most published research findings are false. PLoS medicine, 2(8), e124. https://doi.org/10.1371/journal.pmed.0020124 Luo, Y., Liu, J., Zeng, J., & Pan, H. (2024). Global burden of cardiovascular diseases attributed to low physical activity. American journal of preventive cardiology, 17, 100633. https://doi.org/10.1016/j.ajpc.2024.100633 Ye, Z., Det al. (2025). Association of statins use and genetic susceptibility with incidence of Alzheimer's disease. The journal of prevention of Alzheimer's disease, 12(2), 100025. https://doi.org/10.1016/j.tjpad.2024.100025
Anne Meneghetti, Executive Director of epocrates, is focused on medication management and providing tools for clinicians to better handle challenges from the increasing population of patients who take multiple drugs and are treating a wide variety of conditions. The epocrates app provides access to drug information, pill identification, checks for interactions, and calculates dosing, reducing medication errors and patient confusion. Polypharmacy patients are further at risk when they are taking over-the-counter drugs and supplements, requiring regular medication reconcilation to avoid serious drug interactions. Anne explains, "So epocrates has been around since the late 1990s, and it's the number one mobile medical app in the country in terms of physician usership. And it's both a free model and a subscription model. The main reason why clinicians use epocrates is because of the drug information. So, quickly looking up a drug dose, for example, if a drug needs to be prescribed by weight, what is the calculation for that? And there's no way that clinicians can memorize 8,000 drugs. So having it in a quick, easy-to-use app is really crucial in modern times. And sometimes it's not that the clinician doesn't know the dose of the drug, it's just that validation. When you pick up an app and look and see, yep, that's what I thought it was. And that validation, that sense of confidence, is something really precious for a busy clinician. We also use it for drug interactions." "We find that clinicians really value drug interactions because you can't memorize 8,000 drugs interacting with 8,000 other drugs. And your EHR might tell you if you're trying to prescribe two drugs at the same time, your EHR might tell you, oh, red light, green light, yellow light. But a really good drug reference, like epocrates can tell you, if you're going to prescribe these two drugs together, you need to cut the dose of this one in half and you need to monitor the potassium levels. We find that clinicians really value drug interactions because you can't memorize 8,000 drugs interacting with 8,000 other drugs. And your EHR might tell you if you're trying to prescribe two drugs at the same time, your EHR might tell you, oh, red light, green light, yellow light. But a really good drug reference, like epocrates can tell you, if you're going to prescribe these two drugs together, you need to cut the dose of this one in half and you need to monitor the potassium levels." #epocrates #MedicationManagement #Polypharmacy #DrugInteractions #DigitalHealth epocrates.com Download the transcript
Anne Meneghetti, Executive Director of epocrates, is focused on medication management and providing tools for clinicians to better handle challenges from the increasing population of patients who take multiple drugs and are treating a wide variety of conditions. The epocrates app provides access to drug information, pill identification, checks for interactions, and calculates dosing, reducing medication errors and patient confusion. Polypharmacy patients are further at risk when they are taking over-the-counter drugs and supplements, requiring regular medication reconcilation to avoid serious drug interactions. Anne explains, "So epocrates has been around since the late 1990s, and it's the number one mobile medical app in the country in terms of physician usership. And it's both a free model and a subscription model. The main reason why clinicians use epocrates is because of the drug information. So, quickly looking up a drug dose, for example, if a drug needs to be prescribed by weight, what is the calculation for that? And there's no way that clinicians can memorize 8,000 drugs. So having it in a quick, easy-to-use app is really crucial in modern times. And sometimes it's not that the clinician doesn't know the dose of the drug, it's just that validation. When you pick up an app and look and see, yep, that's what I thought it was. And that validation, that sense of confidence, is something really precious for a busy clinician. We also use it for drug interactions." "We find that clinicians really value drug interactions because you can't memorize 8,000 drugs interacting with 8,000 other drugs. And your EHR might tell you if you're trying to prescribe two drugs at the same time, your EHR might tell you, oh, red light, green light, yellow light. But a really good drug reference, like epocrates can tell you, if you're going to prescribe these two drugs together, you need to cut the dose of this one in half and you need to monitor the potassium levels. We find that clinicians really value drug interactions because you can't memorize 8,000 drugs interacting with 8,000 other drugs. And your EHR might tell you if you're trying to prescribe two drugs at the same time, your EHR might tell you, oh, red light, green light, yellow light. But a really good drug reference, like epocrates can tell you, if you're going to prescribe these two drugs together, you need to cut the dose of this one in half and you need to monitor the potassium levels." #epocrates #MedicationManagement #Polypharmacy #DrugInteractions #DigitalHealth epocrates.com Listen to the podcast here
Subscribe to the video podcast: https://www.youtube.com/@LiveHolPlus/podcastsMental health is not a simple checklist, it is a whole body story. In this hol+ episode, Dr. Taz sits down with Dr. James Greenblatt, a pioneer of integrative and nutritional psychiatry, to rethink how we approach depression, anxiety, ADHD, and eating disorders through labs, nutrients, hormones, and personalized care.Together, they unpack why so much suffering persists despite more medications, how root cause testing changes outcomes, and why simple shifts like correcting vitamin D, B12, iron, thyroid, zinc, and omega 3 can transform mood and resilience. They also explore nutrigenomics for precision dosing, the real limits of 10 minute telehealth med checks, and where tools like ketamine, psychedelics, and lithium orotate fit only after foundations are in place.From practical lab targets and cost effective protocols to the crossroads of food, sleep, screens, and ADHD, this conversation invites us to see mental health not as a diagnosis to medicate, but as a system to understand and support.Dr. Taz and Dr. Greenblatt discuss:The gap between symptom focused care and root cause testingKey labs for mood, vitamin D, B12, iron, thyroid, hormonesWhy micronutrients come first for eating disordersMTHFR, methylfolate, glutathione, and antidepressant responseNutrigenomics for personalized vitamin and mineral dosingThe risks of quick med stacking and 10 minute checksWhere ketamine, psychedelics, and lithium orotate may help, and when they do notADHD, ultra processed foods, sugary drinks, sleep, and screen timeAbout Dr. James Greenblatt, MDDr. James Greenblatt, MD is a board certified psychiatrist and a pioneer of integrative and nutritional psychiatry. For more than three decades he has treated patients with ADHD, depression, anxiety, and eating disorders using personalized protocols that combine conventional care with targeted nutrients and lab guided precision. He is the author of multiple books including Finally Focused and the upcoming Finally Hopeful.Connect further to Hol+ at https://holplus.co/- Don't forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+.Get your copy of The Hormone Shift: Balance Your Body and Thrive Through Midlife and MenopauseStay ConnectedSubscribe to the audio podcast: https://holplus.transistor.fm/subscribeSubscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcastsFollow Dr. Taz on Instagram:https://www.instagram.com/drtazmd/https://www.instagram.com/liveholplus/Join the conversation on X: https://x.com/@drtazmdTikTok: https://www.tiktok.com/@drtazmdFacebook: https://www.facebook.com/drtazmd/Follow Dr. James Greenblatt MD: Website: https://jamesgreenblattmd.com Platform: https://PsychiatryRedefined.org Instagram: https://instagram.com/psychiatry_redefinedDon't forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+00:00 Introduction, testing gap and the B12 tragedy01:31 Pharma model and 10 minute med checks02:37 Framing the crisis and why patients feel stuck05:49 How psychiatry arrived at symptom based meds07:29 What to test, hormones and core nutrients10:49 The Whole Body Map explained12:39 Vitamin D, B12, iron, thyroid, practical targets17:52 Why meds fail without nutrition18:23 Eating disorders, zinc, omega 3, methylfolate24:33 MTHFR, folate, and glutathione26:34 Nutrigenomics and personalized dosing29:51 Ketamine and psychedelics, proceed with caution32:26 Lithium orotate, irritability and dementia research38:57 Polypharmacy, slowing down, doing the work43:21 ADHD, diet, sleep, screens, lifestyle links46:28 Where to learn more, resources, closing (00:00) - Chapter 1 (00:00) - Introduction, testing gap and the B12 tragedy (01:31) - Pharma model and 10 minute med checks (02:37) - Framing the crisis and why patients feel stuck (05:49) - How psychiatry arrived at symptom based meds (07:29) - What to test, hormones and core nutrients (10:49) - The Whole Body Map explained (12:39) - Vitamin D, B12, iron, thyroid, practical targets (17:52) - Why meds fail without nutrition (18:23) - Eating disorders, zinc, omega 3, methylfolate (24:33) - MTHFR, folate, and glutathione (26:34) - Nutrigenomics and personalized dosing (29:51) - Ketamine and psychedelics, proceed with caution (32:26) - Lithium orotate, irritability and dementia research (38:57) - Polypharmacy, slowing down, doing the work (43:21) - ADHD, diet, sleep, screens, lifestyle links (46:28) - Where to learn more, resources, closing
Stream this podcast to learn from experts Alexis E. Horace, PharmD, BCACP,andNimish Patel, PharmD, PhD, AAHIVP, how specialist pharmacists can overcome key barriers to care and apply best practices for optimization of antiretroviral therapy for HIV. Topics covered include: Leveraging pharmacists' expertise to advance HIV treatmentPharmacist roles in HIV care and management The current ART landscapeRegimen simplificationConsideration of patient preferences, health factors, and comorbidities for ART optimizationART management for treatment-experienced patients, including those with multidrug-resistant HIVPresenters:Alexis E. Horace, PharmD, BCACPProfessor of Pharmacy PracticeUniversity of Louisiana at Monroe College of PharmacyNew Orleans CampusCrescentCare Ambulatory Care Clinical Pharmacist, HIV SpecialtyNew Orleans, LouisianaNimish Patel, PharmD, PhD, AAHIVPProfessor of Clinical PharmacyDivision of Clinical PharmacySkaggs School of Pharmacy & Pharmaceutical SciencesUniversity of California, San DiegoLa Jolla, CaliforniaLink to full program: https://bit.ly/41agtqQGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
Dave Mac and Stephen Thomas delve into the alarming issue of iatrogenic deaths, which are deaths caused by medical errors. They discuss the statistics surrounding these errors, the personal stories that highlight the human impact, and the systemic issues within the healthcare system that contribute to these tragedies. The conversation emphasises the need for better reporting, the role of technology in reducing errors, and the importance of patient advocacy. They also explore the cultural shifts needed in healthcare to improve transparency and patient outcomes.https://open.substack.com/pub/theukcarnivore/p/the-doctor-will-maybe-kill-you-now?r=14wb5g&utm_campaign=post&utm_medium=web&showWelcomeOnShare=falseChapters00:00 Understanding Iatrogenic Deaths03:07 The Scale of Medical Errors05:53 Personal Stories and Misdiagnosis08:49 The Need for Better Reporting12:09 Systemic Issues in Healthcare15:00 The Role of Technology in Reducing Errors18:01 Polypharmacy and Its Dangers21:13 Cultural Shifts in Healthcare23:53 Global Implications of Medical Errors26:54 The Importance of Patient Advocacy30:01 The Future of Healthcare and Transparency
Chris Duffin is joined by Anthony Castor for an in-depth exploration of peptides and their role in optimizing health, training, and recovery. Together, they break down the complexities of building peptide protocols—discussing how to identify bottlenecks in your own training or wellness, the art and science of combining interventions effectively (without overcomplicating or wasting resources), and why understanding cellular pathways and mechanisms of action matters. Whether you're curious about cellular medicine, looking to fine-tune your supplement stack, or just want sharper tools in your resilience toolbox, this episode offers practical, actionable wisdom to help you get the most out of your health and performance strategies—without unnecessary complexity. Let's get started! Here are my top three takeaways from the episode: Precision Beats Overload: When it comes to peptides (and training), more isn't always better. Identify your “bottlenecks” and use the least amount of intervention necessary. Streamline your approach and only deploy peptides with mechanisms that authentically support your goals. Understand the Mechanisms: Before layering in another supplement or peptide, take the time to map out which cellular pathways you want to target—and avoid overlap or counterproductive combinations. Knowing howsomething works is crucial to making smart choices (the “why” matters, not just the “what”). Continuous Assessment is Key: Monitor progress with clear performance indicators—whether that's lab work, improved cognition, or how you feel. Be ready to adjust your protocol, rotate interventions, and remove what you no longer need. This episode of the ARCHITECT of RESILIENCE podcast is available on Apple, Spotify & YouTube, and is sponsored by @marekhealth : Performance. Longevity. Optimization.
Longevity & Detox Power of C60: A Deep Dive with a ToxicologistClick On My Website Below To Schedule A Free 15 Min Zoom Call:www.Over40FitnessHacks.comOver 40 Fitness Hacks SKOOL Group!Get Your Whoop4.0 Here!Dr. Joe Nieusma - Live Longer Labs - Toxicologistwww.SuperiorToxicology.comLiveLongerLabs.com (Use code DRJOE15 for a discount)
Send BFTA a commentDr. H breaks down the complex task of deprescribing into six clear steps, starting with the most important and challenging question of all: Who is the patient and why are they suffering?"Bringing Therapy into Med Management"-- a psychotherapy training intensive with Dr. H for psych NPs and PAs this October in Ft Collins https://www.craigheacockmd.com/training/BFTA on IG @backfromtheabysspodcasthttps://www.instagram.com/backfromtheabysspodcast/BFTA/ Dr. Hhttps://www.craigheacockmd.com/podcast-page/
© 2020-2026 Ivy Podcast Discovery LLC
